Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,716 | 189 | 99.7% |
| Education | $17.35 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,977 | 49 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,190 | 37 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,058 | 34 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $459.94 | 31 | $0 (2019) |
| Lilly USA, LLC | $328.15 | 13 | $0 (2021) |
| Novo Nordisk Inc | $223.63 | 13 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $128.19 | 4 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $118.76 | 2 | $0 (2018) |
| DENTSPLY IH Inc. | $99.98 | 1 | $0 (2018) |
| Allergan Inc. | $46.32 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.73 | 1 | AstraZeneca Pharmaceuticals LP ($13.73) |
| 2022 | $48.23 | 3 | Novo Nordisk Inc ($31.61) |
| 2021 | $572.73 | 15 | AstraZeneca Pharmaceuticals LP ($240.46) |
| 2020 | $568.05 | 28 | Janssen Pharmaceuticals, Inc ($167.94) |
| 2019 | $1,970 | 45 | Janssen Pharmaceuticals, Inc ($1,235) |
| 2018 | $1,297 | 55 | Janssen Pharmaceuticals, Inc ($403.63) |
| 2017 | $1,264 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($602.80) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Respiratory | ||||||
| 12/01/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Respiratory | ||||||
| 10/13/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 09/29/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 07/01/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Diabetes | ||||||
| 06/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $106.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $94.40 | General |
| Category: DIABETES | ||||||
| 06/15/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $122.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.58 | General |
| 05/07/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Diabetes | ||||||
| 05/06/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Diabetes | ||||||
| 04/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: DIABETES | ||||||
| 04/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Diabetes | ||||||
| 04/02/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Cardiovascular | ||||||
| 03/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: DIABETES | ||||||
| 01/15/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Diabetes | ||||||
| 01/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: DIABETES | ||||||
| 12/04/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: DIABETES | ||||||
| 11/19/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: Diabetes | ||||||
| 11/13/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 11/06/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.02 | General |
| 10/23/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: DIABETES | ||||||
| 10/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 402 | 684 | $70,200 | $40,856 |
| 2020 | 10 | 818 | 1,393 | $135,780 | $68,797 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 324 | $32,400 | $18,680 | 57.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 73 | 125 | $18,750 | $11,193 | 59.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 64 | 64 | $12,800 | $8,904 | 69.6% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 64 | 64 | $1,920 | $1,155 | 60.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 68 | 73 | $3,650 | $804.68 | 22.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 33 | 34 | $680.00 | $118.32 | 17.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 111 | 461 | $46,100 | $24,130 | 52.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 108 | 302 | $45,300 | $23,937 | 52.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 94 | 94 | $18,800 | $11,384 | 60.6% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 48 | 48 | $2,880 | $2,857 | 99.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 96 | 96 | $2,880 | $1,727 | 60.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 75 | 75 | $2,250 | $1,322 | 58.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 99 | 105 | $5,250 | $1,288 | 24.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 24 | 24 | $960.00 | $920.00 | 95.8% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 76 | 95 | $9,500 | $908.96 | 9.6% |
| 81002 | Urinalysis, manual test | Office | 2020 | 87 | 93 | $1,860 | $322.66 | 17.3% |
About Dr. Amrut Patel, MD
Dr. Amrut Patel, MD is a Internal Medicine healthcare provider based in Cranston, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255419602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amrut Patel, MD has received a total of $5,734 in payments from pharmaceutical and medical device companies, with $13.73 received in 2023. These payments were reported across 192 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($5,716).
As a Medicare-enrolled provider, Patel has provided services to 1,220 Medicare beneficiaries, totaling 2,077 services with total Medicare billing of $109,653. Data is available for 2 years (2020–2021), covering 16 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Cranston, RI
- Active Since 11/02/2006
- Last Updated 03/24/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255419602
Products in Payments
- XARELTO (Drug) $1,185
- FARXIGA (Drug) $1,146
- INVOKANA (Drug) $786.84
- JARDIANCE (Drug) $690.53
- JANUVIA (Drug) $382.94
- TRADJENTA (Drug) $382.30
- TRULICITY (Drug) $254.73
- ENTRESTO (Drug) $128.19
- ELIQUIS (Drug) $118.76
- Implant Dentistry (Device) $99.98
- Ozempic (Drug) $94.73
- STEGLATRO (Drug) $77.00
- BASAGLAR (Drug) $58.61
- Victoza (Drug) $50.61
- FASENRA (Biological) $30.35
- VRAYLAR (Drug) $25.15
- NAMZARIC (Drug) $24.58
- Vascepa (Drug) $24.48
- BYSTOLIC (Drug) $21.74
- LINX Reflux Management System (Device) $21.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cranston
Dr. Gregory Allen, D.o, D.O
Internal Medicine — Payments: $39,714
Dr. Dennis Botelho, Md, MD
Internal Medicine — Payments: $15,096
Dr. Usha Panneerselvam, Md, MD
Internal Medicine — Payments: $11,450
Mr. Stephen Beaupre, Md, MD
Internal Medicine — Payments: $9,665
Dr. James Cardi, M.d, M.D
Internal Medicine — Payments: $6,965
Mrs. Olga Tverskaya, M.d, M.D
Internal Medicine — Payments: $6,262